Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.03 | 0.7 |
mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.12 | 0.7 |
mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.7 |
mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |